Literature DB >> 6491835

Improved chimaeric mouse model confirms that resident peritoneal macrophages are derived solely from bone marrow precursors.

A R Murch, M D Grounds, J M Papadimitriou.   

Abstract

The origin of resident peritoneal macrophages was studied in radiation mouse chimaeras with and without reconstitution of the peritoneum with viable isogeneic peritoneal cells. The selection of host and donor strains were such that the isoenzymes of glucose-6-phosphate isomerase could be used to distinguish host from donor bone marrow derived cells. It was found that the resident peritoneal macrophages were completely replaced by bone marrow donor derived cells within 5-6 weeks. There was little difference between the results from mice which had been additionally reconstituted with peritoneal cells and those which were not.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491835     DOI: 10.1002/path.1711440203

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

1.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.

Authors:  S Fazio; V R Babaev; A B Murray; A H Hasty; K J Carter; L A Gleaves; J B Atkinson; M F Linton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

2.  CX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer.

Authors:  Kevin M Hart; Edward J Usherwood; Brent L Berwin
Journal:  Immunol Cell Biol       Date:  2014-03-11       Impact factor: 5.126

3.  WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.

Authors:  Ulrich Matt; Omar Sharif; Rui Martins; Tanja Furtner; Lorene Langeberg; Riem Gawish; Immanuel Elbau; Ana Zivkovic; Karin Lakovits; Olga Oskolkova; Bianca Doninger; Andreas Vychytil; Thomas Perkmann; Gernot Schabbauer; Christoph J Binder; Valery N Bochkov; John D Scott; Sylvia Knapp
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.